DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPTLC METHOD FOR DETERMINATION OF APIXABAN AS BULK DRUG
Objective: To develop and validate simple, sensitive stability indicating HPTLC (High performance thin layer chromatography) method for apixaban.
Methods: The chromatographic separation was performed on aluminium plates precoated with silica gel 60 F254 using toluene: ethyl acetate: methanol (3:6:1 v/v/v) as mobile phase followed by densitometric scanning at 279 nm.
Results: The chromatographic condition shows sharp peak of apixaban at Rf value of 0.38±0.03. Stress testing was carried out according to international conference on harmonization (ICH)Q1A (R2) guidelines and the method was validated as per ICH Q2(R1) guidelines. The calibration curve was found to be linear in the concentration range of 100-500 ng/band for apixaban. The limit of detection and quantification was found to be 11.66ng/bandand35.33ng/band, respectively.
Conclusion: A new simple, sensitive, stability indicating high performance thin layer chromatographic (HPTLC) method has been developed and validated for the determination of apixaban.
2. https: //rxlist.com [Last accessed on 13 May 2018]
3. http://drugs.com [Last accessed on 13 May 2018]
4. https: //medpagetoday.com [Last accessed on 13 May 2018]
5. https://pfizer.com [Last accessed on 13 May 2018]
6. Prabhune SS, Jaguste RS, Kondalkar PL, Pradhan NS. Stability-indicating high-performance liquid chromatographic determination of apixaban in the presence of degradation products. Sci Pharm 2014;82:777-85.
7. Landge SB, Jadhav SA, Dahale SB, Solanki PV, Bembalkar SR, Mathad VT. Development and validation of stability indicating RP-HPLC method on core shell column for determination of degradation and process related impurities of apixaban-an anticoagulant drug. AJAC 2015;6:539-50.
8. El-Bagary RI, Elkady EF, Farid NA, Youssef NF. Corrigendum to validated spectrofluorimetric methods for the determination of apixaban and tirofiban hydrochloride in pharmaceutical formulations. Spectrochim Acta A Mol Biomol Spectrosc 2017;174:326–30.
9. Jain HK, Nikam VK. Development and validation of HPTLC method for determination apixaban in bulk and tablets. Int J Appl Pharm 2017;9:78-2.
10. Delavennea X, Mismetti P, Basset T. Rapid determination of apixaban concentration in human plasma by liquid chromatography/tandem mass spectrometry: application to pharmacokinetic study. J Pharm Biomed Anal 2013;78:150–3.
11. Zheng N, Yuana L, Ji QC, Mangus H, Song Y, Frost C, et al. Center punch and whole spot bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS. J Chromatogr B 2015;988:66-74.
12. Ashok CV, Sailaja BBV, Pravin KA. Stability indicating reverse phase high performance liquid chromatographic method for simultaneous estimation of labetalol and its degradation products in tablet dosage forms. Asian J Pharm Clin Res 2016;9 Suppl 2:242-9.
13. Neelima MS, Gandhi BM, Raju VB, Sumanth KR, Srinivas K, Mounika P, et al. Development and validation of stability indicating reverse phase high performance liquid chromatography method for simultaneous estimation of atenolol, hydrochlorothiazide and losartan in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res 2016;9:118-24.
14. Athavia BA, Dedania ZR, Dedania RR, Swamy SMV, Prajapati CB. Stability indicating HPLC method for determination of vilazodone hydrochloride. Int J Curr Pharm Res 2017; 9:123-9.
15. Virani P, Sojitra R, Raj H, Jain V. Chromatographic method for irbesartan and its combination with other drug. J Crit Rev 2015;2:7-11.
16. ICH. Stability testing of few drug substances and products Q1A (R2), International Conference on Harmonisation; 2003.
17. ICH. Harmonized tripartite guideline, stability testing: Photostability testing of new drug substances and products, Q1 (B), International Conference on Harmonisation; 1996.
18. ICH. Validation of analytical procedures: text and methodology Q2 (R1), International Conference on Harmonisation; 2005.
This work is licensed under a Creative Commons Attribution 4.0 International License.